Medicine by Alexandros G. Sfakianakis,Αλέξανδρος Γ. Σφακιανάκης: Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapy.

Τρίτη 10 Δεκεμβρίου 2019

Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapy.

Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapy.:

Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapy.

J Dtsch Dermatol Ges. 2019 Dec 09;:

Authors: Stefanou MI, Gepfner-Tuma I, Brendle C, Kowarik M, Meiwes A, Eigentler T, Müller A, Garbe C, Ziemann U, Tabatabai G, Forschner A

PMID: 31814289 [PubMed - as supplied by publisher]

Medicine by Alexandros G. Sfakianakis,Αλέξανδρος Γ. Σφακιανάκης

Πληροφορίες

Ετικέτες

Τρίτη 10 Δεκεμβρίου 2019

Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapy.

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου